Markers of Right Ventricular Dysfunction Predict Maximal Exercise Capacity After Left Ventricular Assist Device Implantation.


Journal

ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109

Informations de publication

Date de publication:
01 03 2021
Historique:
entrez: 25 2 2021
pubmed: 26 2 2021
medline: 1 6 2021
Statut: ppublish

Résumé

Although left ventricular assist device (LVAD) improves functional capacity, on average LVAD patients are unable to achieve the aerobic capacity of normal healthy subjects or mild heart failure patients. The aim of this study was to examine if markers of right ventricular (RV) function influence maximal exercise capacity. This was a single-center prospective study that enrolled 20 consecutive HeartWare ventricular assist device patients who were admitted at the Freeman Hospital (Newcastle upon Tyne, United Kingdom) for a heart transplant assessment from August 2017 to October 2018. Mean peak oxygen consumption (Peak VO2) was 14.0 ± 5.0 ml/kg/min, and mean peak age and gender-adjusted percent predicted oxygen consumption (%VO2) was 40.0% ± 11.5%. Patients were subdivided into two groups based on the median peak VO2, so each group consisted of 10 patients (50%). Right-sided and pulmonary pressures were consistently higher in the group with poorer exercise tolerance. Patients with poor exercise tolerance (peak VO2 below the median) had higher right atrial pressures at rest (10.6 ± 6.4 vs. 4.3 mmHg ± 3.2; p = 0.02) and the increase with passive leg raising was significantly greater than those with preserved exercise tolerance (peak VO2 above the median). Patients with poor functional capacity also had greater RV dimensions (4.4 cm ± 0.5 vs. 3.7 cm ± 0.5; p = 0.02) and a higher incidence of significant tricuspid regurgitation (moderate or severe tricuspid regurgitation in five patients in the poor exercise capacity group vs. none in the preserved exercise capacity group; p = 0.03). In conclusion, echocardiographic and hemodynamic markers of RV dysfunction discriminate between preserved and nonpreserved exercise capacity in HeartWare ventricular assist device patients.

Identifiants

pubmed: 33627602
doi: 10.1097/MAT.0000000000001245
pii: 00002480-202103000-00011
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

284-289

Informations de copyright

Copyright © ASAIO 2020.

Déclaration de conflit d'intérêts

Disclosure: The authors have no conflicts of interest to report.

Références

Rogers JG, Aaronson KD, Boyle AJ, et al.; HeartMate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010; 55:1826–1834
Kirklin JK, Xie R, Cowger J, et al. Second annual report from the ISHLT mechanically assisted circulatory support registry. J Heart Lung Transplant. 2018; 37:685–691
Estep JD. 3D Echocardiography and ventricular unloading with continuous flow LVAD: Potential advantages to optimize patient outcome. JACC Cardiovasc Imaging. 2018; 11:170–172
Loyaga-Rendon RY, Plaisance EP, Arena R, Shah K. Exercise physiology, testing, and training in patients supported by a left ventricular assist device. J Heart Lung Transplant. 2015; 34:1005–1016
Adamopoulos S, Corrà U, Laoutaris ID, et al. Exercise training in patients with ventricular assist devices: A review of the evidence and practical advice. A position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019; 21:3–13
Schmidt T, Bjarnason-Wehrens B, Mommertz S, et al. Development of exercise-related values in heart failure patients supported with a left ventricular assist device. Int J Artif Organs. 2019; 42:201–206
Kutty RS, Parameshwar J, Lewis C, et al. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension. Eur J Cardiothorac Surg. 2013; 43:1237–1242
Morgan JA, Paone G, Nemeh HW, et al. Impact of continuous-flow left ventricular assist device support on right ventricular function. J Heart Lung Transplant. 2013; 32:398–403
Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006; 25:1–6
Lee S, Kamdar F, Madlon-Kay R, et al. Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function. J Heart Lung Transplant. 2010; 29:209–215
Jung MH, Gustafsson F. Exercise in heart failure patients supported with a left ventricular assist device. J Heart Lung Transplant. 2015; 34:489–496
Shah SP, Mehra MR. Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes. Indian Heart J. 2016; 68Suppl 1S45–S51
Koshy A, Bouzas-Cruz N, Okwose NC, et al. Left ventricular filling pressures contribute to exercise limitation in patients with continuous flow left ventricular assist devices. ASAIO J. 2020; 66:247–252
Bouchez S, Van Belleghem Y, De Somer F, De Pauw M, Stroobandt R, Wouters P. Haemodynamic management of patients with left ventricular assist devices using echocardiography: The essentials. Eur Heart J Cardiovasc Imaging. 2019; 20:373–382
Stainback RF, Estep JD, Agler DA, et al.; American Society of Echocardiography. Echocardiography in the management of patients with left ventricular assist devices: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2015; 28:853–909
Abe Y, Akamatsu K, Furukawa A, et al. Pre-load—induced changes in forward LV stroke and functional mitral regurgitation. J Am Coll Cardiol Imaging. 2017; 10:611–618
Balady GJ, Arena R, Sietsema K, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: A scientific statement from the American Heart Association. Circulation. 2010; 122:191–225
Wasserman K, Hansen JE, Sue DY, et al. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. 2012, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins
Bernal W, Martin-Mateos R, Lipcsey M, et al. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl. 2014; 20:54–62
Vignati C, Apostolo A, Cattadori G, et al. Lvad pump speed increase is associated with increased peak exercise cardiac output and vo2, postponed anaerobic threshold and improved ventilatory efficiency. Int J Cardiol. 2017; 230:28–32
Abshire M, Dennison Himmelfarb CR, Russell SD. Functional status in left ventricular assist device-supported patients: A literature review. J Card Fail. 2014; 20:973–983
Jung MH, Hansen PB, Sander K, et al. Increasing pump speed during exercise improves peak oxygen consumption in heart failure patients supported with continuous-flow left ventricular assist devices—A double-blind randomized study. J Heart Lung Transplant. 2014; 33:S13
Martina J, de Jonge N, Rutten M, et al. Exercise hemodynamics during extended continuous flow left ventricular assist device support: The response of systemic cardiovascular parameters and pump performance. Artif Organs. 2013; 37:754–762
Mezzani A, Pistono M, Agostoni P, et al. Exercise gas exchange in continuous-flow left ventricular assist device recipients. PLoS One. 2018; 13:e0187112
Moss N, Rakita V, Lala A, et al. Hemodynamic response to exercise in patients supported by continuous flow left ventricular assist devices. JACC Heart Fail. 2020; 8:291–301
Simon MA, Kormos RL, Gorcsan J III, et al. Differential exercise performance on ventricular assist device support. J Heart Lung Transplant. 2005; 24:1506–1512
Biais M, Vidil L, Sarrabay P, Cottenceau V, Revel P. Changes in stroke volume induced by passive leg raising in spontaneously breathing patients: Comparison between echocardiography and Vigileo TM /FloTrac TM device. Crit Care. 2009; 13:1–8
Starling EH. The Linacre Lecture on the Law of the Heart. 1918, London: Longmans, Green and Co
Katz AM. The descending limb of the Starling curve and the failing heart. Circulation. 1965; 32:871–875
Hummel YM, Bugatti S, Damman K, et al. Functional and hemodynamic cardiac determinants of exercise capacity in patients with systolic heart failure. Am J Cardiol. 2012; 110:1336–1341
Clark AL, Swan JW, Laney R, Connelly M, Somerville J, Coats AJ. The role of right and left ventricular function in the ventilatory response to exercise in chronic heart failure. Circulation. 1994; 89:2062–2069
Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol. 1995; 25:1143–1153
Baker BJ, Willen MM, Boyd CM, Dinh H, Franciosa JA. Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. Am J Cardiol. 1985; 54:596–699
Witte KK, Nikitin NP, De Silva R, Cleland JG, Clark AL. Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic heart failure. Heart. 2004; 90:1144–1150
Rubis P, Podolec P, Kopec G, Olszowska M, Tracz W. The dynamic assessment of right-ventricular function and its relation to exercise capacity in heart failure. Eur J Heart Fail. 2010; 12:260–267
Estep JD, Stainback RF, Little SH, Torre G, Zoghbi WA. The role of echocardiography and other imaging modalities in patients with left ventricular assist devices. JACC Cardiovasc Imaging. 2010; 3:1049–1064
Uriel N, Levin AP, Sayer GT, et al. Left ventricular decompression during speed optimization ramps in patients supported by continuous-flow left ventricular assist devices: Device-specific performance characteristics and impact on diagnostic algorithms. J Card Fail. 2015; 21:785–791
Imamura T, Kinugawa K, Kato N, et al. Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device. Circ J. 2014; 78:625–633
Jung MH, Houston B, Russell SD, Gustafsson F. Pump speed modulations and sub-maximal exercise tolerance in left ventricular assist device recipients: A double-blind, randomized trial. J Heart Lung Transplant. 2017; 36:36–41
Mezzani A, Pistono M, Corrà U, et al. Systemic perfusion at peak incremental exercise in left ventricular assist device recipients: Partitioning pump and native left ventricle relative contribution. IJC Heart Vessel. 2014; 4:40–45
Hayward CS, Salamonsen R, Keogh AM, et al. Effect of alteration in pump speed on pump output and left ventricular filling with continuous-flow left ventricular assist device. ASAIO J. 2011; 57:495–500
Nakanishi K, Homma S, Han J, et al. Usefulness of tricuspid annular diameter to predict late right sided heart failure in patients with left ventricular assist device. Am J Cardiol. 2018; 122:115–120
Gonzalez-Fernandez O, Bouzas-Cruz N, Ferrera C, et al. Effect of preoperative tricuspid and/or mitral regurgitation on development of late right-sided heart failure after insertion of the heartware left ventricular assist device. Am J Cardiol. 2020; 125:236–243

Auteurs

Noelia Bouzas-Cruz (N)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Cardiology Department, University of Santiago de Compostela, Santiago de Compostela, Spain.

Aaron Koshy (A)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Oscar Gonzalez-Fernandez (O)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Carlos Ferrera (C)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Thomas Green (T)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Nduka C Okwose (NC)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Cardiology Department, University of Santiago de Compostela, Santiago de Compostela, Spain.
Newcastle University, Biosciences and Translational and Clinical Research Institutes, Newcastle upon Tyne, United Kingdom.

Andrew Woods (A)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Sian Tovey (S)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Nicola Robinson-Smith (N)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Adam K Mcdiarmid (AK)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Gareth Parry (G)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Jose R Gonzalez-Juanatey (JR)

Newcastle University, Biosciences and Translational and Clinical Research Institutes, Newcastle upon Tyne, United Kingdom.

Stephan Schueler (S)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Djordje G Jakovljevic (DG)

Newcastle University, Biosciences and Translational and Clinical Research Institutes, Newcastle upon Tyne, United Kingdom.

Guy Macgowan (G)

From the Department of Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Newcastle University, Biosciences and Translational and Clinical Research Institutes, Newcastle upon Tyne, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH